At the TMA/The Deal's Distressed Investing Conference in January, Rothchild's David Resnick, Cerberus Capital Management LP's Kevin Cross and KPS Capital Partners LP's David Shapiro discussed the opportunities and challenges for strategics investing in distressed assets. - Maria Woehr
Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
